Keisei Electric Railway shares rose sharply on its plan to sell part of its stake in the Tokyo Disney Resort operator for more than $400 million. The railway operator's shares were recently 5.5% ...

A bankruptcy judge on Monday delayed a hearing in conspiracy theorist Alex Jones’ effort to stop the satirical news outlet ...

Concert-venue developer Venu Holding said its initial public offering of 1.2 million shares priced at $10 each. As of Nov. 12, the company expected to sell 1 million shares for $10 a share. Shares ...

HP is waiting for consumers to upgrade their personal computers, which is dragging on sales for the time being. The company forecast adjusted per-share earnings between 70 cents and 76 cents for its ...

Manchester United, which reported fiscal first-quarter results Tuesday, remains in the early stages of its turnaround, ...

Shares of travel platform Mondee Holdings were trading in the red in after-hours action following news Chief Executive Prasad Gundumogula would take a leave of absence, effective Nov. 25. He will ...

Acadia Pharmaceuticals on Tuesday said it entered into an exclusive worldwide license agreement with Saniona to develop and commercialize SAN711.

Exelixis plans to meet with the FDA's oncologic drugs advisory committee in March to discuss the drug's potential new uses. The meeting will review the safety and effectiveness of the cancer drug ...

Communications services companies rose to all-time highs amid merger speculation. Japanese media and electronics giant Sony is exploring a buyout of Japanese media company Kadokawa, maker of the ...

Shares of Dell Technologies tumbled after the company issued fourth-quarter guidance that missed analyst expectations. The stock fell 11%, to $126.85, in after-hours trading Tuesday. Shares ended the ...

Consumer companies rose amid mixed signals on the outlook for holiday sales. Online megastore Amazon.com rallied, testing all-time highs, amid optimism about digital sales on Black Friday. Kohl's cut ...

The White House said it's moving to make the federal health insurance plans pay for anti-obesity drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound for people who are obese, even if they don ...